Schott Pharmaceutical Packaging continues to experience growth in Russia and now plans to increase the production capacities at its plant in Zavolzhe by more than 50%.

“Expanding our presence in Russia represents an important strategic step for the benefit of our customers,” emphasises Prof. Udo Ungeheuer, Chairman of the Board of Management of Schott AG.

“We are seeing continued growth in demand for locally manufactured primary packaging that also meets all of the international standards for quality. This will result in shorter delivery routes and better export opportunities for our customers,” he added.

The Russian pharmaceutical industry has experienced double-digit growth in recent years. State initiatives like the government’s “Pharma 2020” strategy, which seeks to encourage local manufacturing of high-quality medications according to the Good Manufacturing Practice (GMP) standard, will continue this development.

Schott became the first international manufacturer in Russia to open a new GMP-compliant pharmaceutical packaging plant in the spring of 2011.

By setting up new production lines for vials and ampoules, the company has demonstrated consistency in taking the next step toward continuing to offer its Russian customers shorter delivery times.